CX Institutional’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
AT
CISOA
DJSG
CIM
AC
MPWT
NAM
CX Institutional's RMD Position: Q2 2026 in Review
CX Institutional increased its ResMed (RMD) stake by 49% in Q2 2026, buying an estimated $157K and bringing the position to 2,297 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #500.
CX Institutional first reported a position in RMD in Q4 2018 and has held it in 25 quarters since. The position peaked at $481K in Q3 2025. 147 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- CX Institutional held 2,297 shares of ResMed worth $448K as of Q2 2026.
- CX Institutional bought 757 ResMed shares in Q2 2026, an estimated $157K.
- ResMed made up 0.01% of CX Institutional's portfolio in Q2 2026, its #500 holding.
- CX Institutional first reported a position in ResMed in Q4 2018 and has held it in 25 quarters since.
- CX Institutional's ResMed position peaked at $481K in Q3 2025.
- 147 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.